Evidence map›Paper›PMID 29769229›Full record

ArticleJournal of the American Society of Nephrology : JASN2018

The Underestimated Burden of Monogenic Diseases in Adult-Onset ESRD.

Emilie Cornec-Le Gall, Peter C Harris

Open access · bronzeAbstract readEditorialComment
In one paragraph

Article in Journal of the American Society of Nephrology : JASN, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.7field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Chronic Kidney Disease of unexplained cause (CKDx): a consensus statement by the Genes & Kidney Working Group of the ERA.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2025
    Article
  3. Article
  4. Observational
  5. Article
  6. Article
  7. Targeted broad-based genetic testing by next-generation sequencing informs diagnosis and facilitates management in patients with kidney diseases.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2021
    Article
4 · The record

Corrections and comments

  • Comment on
    2018
5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Emilie Cornec-Le GallDépartement de Néphrologie, Hémodialyse et Transplantation Rénale, Centre Hospitalier Universitaire de Brest, Brest, France; emilie.cornec-legall@chu-brest.fr harris.peter@mayo.edu.
Peter C HarrisDivision of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota emilie.cornec-legall@chu-brest.fr harris.peter@mayo.edu.ORCID 0000-0002-5304-6593
Inserm · FRMayo Clinic · US

Funding

Pilot and FeasibilityP30DK090728 · NIDDK · MAYO CLINIC ROCHESTER · PI ROMERO, MICHAEL F. · 2010 to 2019
$11.8M
Transgenic and Knockout Models of ADPKDR01DK059597 · NIDDK · MAYO CLINIC ROCHESTER · PI Peter C. Harris · 2002 to 2026
$9.5M
NIDDK NIH HHS P30 DK090728NIDDK NIH HHS R01 DK059597
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Adaptor Proteins, Signal TransducingAdultCytoskeletal ProteinsGene DeletionHumansKidney Diseases, CysticKidney Failure, ChronicMembrane ProteinsAdaptor Proteins, Signal TransducingCytoskeletal ProteinsMembrane ProteinsNPHP1 protein, humanAdult ESRDMolecular DiagnosticsNPHP

Identifiers

PMID29769229
PMCPMC6054347
OpenAlexW2803480462

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.